Effect of DA-9701 on the Gastrointestinal Motility in the Streptozotocin-Induced Diabetic Mice.

Changyoon HaHeejin KimRari ChaJaemin LeeSangsoo LeeJung-Hwa RyuHyunjin KimOk Jae Lee

Published in: Journal of clinical medicine (2021)

DA-9701 improved GI contractility without affecting blood sugar and body weight in diabetic mice. DA-9701 could improve the decreased GI motility and clinical symptoms in progressive diabetic patients.

Keyphrases

body weight
diabetic rats
biofilm formation
oxidative stress
multiple sclerosis
high glucose
high fat diet
type diabetes
drug induced
diabetic nephropathy
staphylococcus aureus
sleep quality
depressive symptoms
cystic fibrosis
endothelial cells
skeletal muscle